Published in Proc Natl Acad Sci U S A on August 16, 2010
β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation. Mol Biol Cell (2013) 1.29
CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci (2012) 1.24
Cdc42 promotes transendothelial migration of cancer cells through β1 integrin. J Cell Biol (2012) 1.20
Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res (2011) 1.15
Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene (2013) 1.13
Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion. J Cell Biol (2012) 1.12
β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Res (2011) 1.05
Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis. Proc Natl Acad Sci U S A (2013) 1.04
The primacy of β1 integrin activation in the metastatic cascade. PLoS One (2012) 1.03
αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02
Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Mol Biol Cell (2013) 1.02
β1 and β4 integrins: from breast development to clinical practice. Breast Cancer Res (2014) 1.00
Novel strategies for the treatment of chondrosarcomas: targeting integrins. Biomed Res Int (2013) 0.98
Specific β-containing integrins exert differential control on proliferation and two-dimensional collective cell migration in mammary epithelial cells. J Biol Chem (2012) 0.95
β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy. Cell Adh Migr (2012) 0.94
DNA damage response genes and the development of cancer metastasis. Radiat Res (2014) 0.93
Arg kinase regulates epithelial cell polarity by targeting β1-integrin and small GTPase pathways. Curr Biol (2011) 0.92
Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes. J Proteome Res (2013) 0.90
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo. Breast Cancer Res (2012) 0.90
How integrins control breast biology. Curr Opin Cell Biol (2013) 0.89
Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma. PLoS One (2011) 0.89
Elucidation of the Roles of Tumor Integrin β1 in the Extravasation Stage of the Metastasis Cascade. Cancer Res (2016) 0.87
New mechanistic insights of integrin β1 in breast cancer bone colonization. Oncotarget (2015) 0.86
A cell-ECM screening method to predict breast cancer metastasis. Integr Biol (Camb) (2015) 0.85
Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells. Cancer Res (2012) 0.84
Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion. Surgery (2013) 0.84
Occupy tissue: the movement in cancer metastasis. Cell Adh Migr (2012) 0.83
β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model. Sci Rep (2012) 0.82
Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility. J Biol Chem (2013) 0.82
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin. Oncogene (2013) 0.82
p53 in cell invasion, podosomes, and invadopodia. Cell Adh Migr (2014) 0.82
NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration. Mol Cell Biol (2016) 0.80
Cellular microenvironment influences the ability of mammary epithelia to undergo cell cycle. PLoS One (2011) 0.79
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. PLoS One (2015) 0.78
When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase. Cells (2014) 0.78
Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray. Int J Clin Exp Pathol (2015) 0.78
In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech (2017) 0.78
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin. Breast Cancer Res Treat (2016) 0.77
Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model. BMC Cancer (2014) 0.76
A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype. Dig Dis Sci (2013) 0.76
High mannose-binding Pseudomonas fluorescens lectin (PFL) downregulates cell surface integrin/EGFR and induces autophagy in gastric cancer cells. BMC Cancer (2016) 0.76
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. Mol Biol Cell (2017) 0.75
Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models. PLoS One (2017) 0.75
Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER-/PR- Breast Cancers, a Chromosome 17 C-HPP Study. J Proteome Res (2015) 0.75
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Oncotarget (2016) 0.75
Integrins in development and cancer. Biophys Rev (2013) 0.75
Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC). Oncotarget (2016) 0.75
Molecular mechanisms of asymmetric divisions in mammary stem cells. EMBO Rep (2016) 0.75
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61
Mutant p53 drives invasion by promoting integrin recycling. Cell (2009) 4.75
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell (2006) 4.48
Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell (2004) 4.34
PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol (2009) 3.15
Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res (2006) 2.86
Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A (2007) 2.64
Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol (2008) 2.61
Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55
Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev (2004) 2.49
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment. Breast Cancer Res Treat (2009) 2.34
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev (1994) 2.05
Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol (2003) 1.99
Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res (2008) 1.83
ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J (2008) 1.82
Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol (2008) 1.82
Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem (2003) 1.77
Beta 1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol (1997) 1.75
The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol (2002) 1.75
Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J (2007) 1.32
Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res (2009) 1.32
Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res (2010) 1.32
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol Cancer Ther (2009) 1.09
Genomic amplicons target vesicle recycling in breast cancer. J Clin Invest (2009) 1.04
Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene (2010) 1.00
An activating beta1 integrin mutation increases the conversion of benign to malignant skin tumors. Cancer Res (2009) 0.96
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A (1992) 8.59
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79
Polyomavirus origin for DNA replication comprises multiple genetic elements. J Virol (1983) 2.89
Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell (1998) 2.64
Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med (2000) 2.61
Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol (1998) 2.48
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol Cell Biol (2000) 2.47
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol (1994) 2.32
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene (2007) 2.31
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci U S A (2000) 2.19
Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev (1994) 2.05
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol (1994) 2.03
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol (2001) 2.02
CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol (1998) 1.93
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res (2000) 1.86
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73
Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol (2001) 1.68
Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation. Mol Cell Biol (1997) 1.66
Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol (1992) 1.62
Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J Biol Chem (1998) 1.61
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res (1998) 1.60
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. Hum Gene Ther (1999) 1.60
Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci U S A (1995) 1.56
Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene (2000) 1.46
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr Biol (2001) 1.45
Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene (2001) 1.42
The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis. Exp Cell Res (1999) 1.41
Activated neu induces rapid tumor progression. J Biol Chem (1996) 1.39
Telomerase activity in normal and malignant murine tissues. Oncogene (1995) 1.34
Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins. J Biol Chem (2001) 1.29
Role of Gab2 in mammary tumorigenesis and metastasis. Oncogene (2007) 1.27
Transgenic mouse models of human breast cancer. Oncogene (2000) 1.27
neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol (1997) 1.27
Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J Biol Chem (2000) 1.25
Sequence-dependent DNA replication in preimplantation mouse embryos. Mol Cell Biol (1985) 1.16
Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants. Mol Cell Biol (1984) 1.16
Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene (1995) 1.16
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther (1996) 1.16
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol (2000) 1.15
Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc Natl Acad Sci U S A (1996) 1.15
The polyomavirus enhancer comprises multiple functional elements. J Virol (1988) 1.14
Transgenic mouse models of mammary tumorigenesis. Cancer Surv (1993) 1.14
Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene (2007) 1.13
Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene (1995) 1.13
Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J Cell Sci (1999) 1.09
Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene (2001) 1.08
PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene (1993) 1.06
Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res (2000) 1.06
Active signaling by Neu in transgenic mice. Oncogene (1998) 1.03
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia (1997) 1.00
Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther (1998) 1.00
Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene (2010) 1.00
eIF4F suppression in breast cancer affects maintenance and progression. Oncogene (2012) 0.99
Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. Proc Natl Acad Sci U S A (1995) 0.99
Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes (1993) 0.98
Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene (2010) 0.97
Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Mol Cell Biol (1999) 0.96
Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res (1999) 0.94
Activation of the Src family of tyrosine kinases in mammary tumorigenesis. Adv Cancer Res (1994) 0.93
Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha. Gene Ther (1997) 0.93
Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc Natl Acad Sci U S A (1997) 0.91
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. Gene Ther (1998) 0.91
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice. Int J Cancer (1998) 0.91
Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy. Int J Cancer (1997) 0.90
The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility. Oncogene (2009) 0.89
Mammary gland neoplasia: insights from transgenic mouse models. Bioessays (2000) 0.89
Mammary tumorigenesis and metastasis in transgenic mice. Semin Cancer Biol (1994) 0.88
Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors. Ann N Y Acad Sci (1999) 0.87
Shc is required for ErbB2-induced inhibition of apoptosis but is dispensable for cell proliferation and disruption of cell polarity. Oncogene (2009) 0.86
Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation. J Appl Physiol (1985) (1987) 0.85
Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol Carcinog (1996) 0.85
Histopathology of transgenic mouse mammary tumors (a short atlas). Semin Cancer Biol (1995) 0.84
Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res (1997) 0.83
Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis (1996) 0.83
A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor alpha expressed from an adenovirus vector induces an antitumor response with reduced toxicity. Cancer Gene Ther (1999) 0.82
Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity. Biochem Pharmacol (1994) 0.82
Tumour therapy in mice using adenovirus vectors expressing human TNFa. Int J Oncol (1998) 0.81
The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival. Oncogene (2012) 0.81
Polyomavirus-plasmid recombinants capable of replicating have an enhanced transforming potential. Mol Cell Biol (1983) 0.79
Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes. Neuroscience (2001) 0.78
Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes. Neuroscience (1997) 0.78
Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas. Cell Growth Differ (1995) 0.78
Preliminary observations on the effects of hydrocortisone and sodium methohexital on development of Sarcophaga (Curranea) tibialis Macquart (Diptera: Sarcophagidae), and implications for estimating post mortem interval. Forensic Sci Int (2001) 0.77
Transgenic models of breast cancer metastasis. Cancer Treat Res (1996) 0.77
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth. Gene Ther (2002) 0.77
Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. J Neural Transm Suppl (1994) 0.77
Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species. Biochem Pharmacol (1992) 0.77
Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus. Neurosci Lett (1995) 0.76
Oncogene mediated signal transduction in transgenic mouse models of human breast cancer. Adv Exp Med Biol (2000) 0.76
Production and secretion of progesterone in vitro and presence of platelet activating factor (PAF) in early pregnancy of the marsupial, Macropus eugenii. Reprod Fertil Dev (1993) 0.76
Lipid peroxidation in the freshwater shrimp Caridina nilotica as a biomarker of Roundup(®) herbicide pollution of freshwater systems in South Africa. Water Sci Technol (2012) 0.75
La Amistad: starting an inpatient program for severely disturbed young adults. Hosp Community Psychiatry (1974) 0.75
Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl? J Neural Transm Suppl (1994) 0.75
Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties. Prog Brain Res (1995) 0.75
Aliphatic N-methylpropargylamines as potential neurorescue agents. Restor Neurol Neurosci (1998) 0.75
Effect of laundry activities on in-stream concentrations of linear alkylbenzene sulfonate in a small rural South African river. Sci Total Environ (2009) 0.75